Twin Path Ventures led the seed financing for the Belfast biotechnology firm to accelerate its preclinical discovery programmes.
"Ten years ago, I began combining financial modeling expertise with computational biology to create a drug discovery platform. Evolution has spent billions of years perfecting natural defense mechanisms, and now we’re using AI to unlock this wisdom. This isn’t just professional for me; my father died from a drug-resistant infection our healthcare system couldn’t treat. At Queen’s, I built AMPLY to tackle deadly diseases differently, creating technology that will save lives when current treatments fail."
The Belfast biotechnology company raised the capital from investors including Co-fund NI, QUBIS, and the Halo Business Angel Network.
"It is exciting to be able to advance the commercial development of AMPLY Discovery thanks to the tremendous support of our investors and Queen’s University Belfast. The development of initial research in this domain started out almost a decade ago when I considered adopting AI and machine learning techniques I had worked with in financial markets for the computational biology domain."
The Belfast startup has closed a seed round backed by Halo and Co Fund NI.
"This has been a very exciting time for the company and this fresh investment will enable Taggled to scale up, increase headcount and fully launch our product in European and US markets in the near future. Our aim is to offer vloggers a simple, informative tool for creating dynamic and interactive content for their users and this funding will maximise our ability to do this."
